Peter Francis - 01 Dec 2025 Form 4 Insider Report for Benitec Biopharma Inc. (BNTC)

Role
Director
Signature
/s/ Peter Francis
Issuer symbol
BNTC
Transactions as of
01 Dec 2025
Net transactions value
$0
Form type
4
Filing time
03 Dec 2025, 16:17:12 UTC
Previous filing
11 Dec 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Francis Peter Director C/O BENITEC BIOPHARMA INC., 3940 TRUST WAY, HAYWARD /s/ Peter Francis 03 Dec 2025 0001808850

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNTC Options (right to buy) Award $0 +35,000 $0.000000 35,000 01 Dec 2025 Common Stock 35,000 $12.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026.